Certified by Founder Lodge
Mercy BioAnalytics, Inc.
United States - Natick, Massachusetts
START UP
1 Disclosed Funding Rounds $41,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mercy BioAnalytics is on a mission to save lives and relieve suffering across the globe through the early detection of cancer. We have developed a novel liquid biopsy assay platform which int
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 04 ,2023 | Series A | $41,000,000 | |
| September, 04 ,2025 | Series B | $59,000,000.00 |
Hatteras Venture Partners
iSelect Fund
Sozo Ventures
Broadway Angels
BrightEdge - American Cancer Society
Novalis LifeSciences LLC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
